Trademarkia Logo

United Kingdom

£
Registered

on 20 Apr 2023

Last Applicant/ Owned by

Acuitas Therapeutics, Inc.

6190 Agronomy Rd Suite 405, University of British Columbia

Vancouver BRITISH COLUMBIA, , V6T1W5

Serial Number

UK00003902781 filed on 20th Apr 2023

Registration Number

UK00003902781 registered on
22nd Sept 2023

Correspondent Information

Grünecker

The Clubhouse, 20 St Andrew Street

London,

EC4A 3AG

ACUITAS THERAPEUTICS

lipids, lipid nanoparticles, lipid formulations, and nucleic acids, messenger rna, for scientific purposes, research purposes, or laboratory use. p Read More

Classification Information


Class [1]
Chemical Products


Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, messenger RNA, for scientific purposes, research purposes, or laboratory use.

Class [5]
Pharmaceutical Products


Pharmaceutical preparations, such as, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics; pharmaceutical preparations comprised of nucleic acids, messenger RNA, and lipid nanoparticles; pharmaceutical preparations comprised of lipid nanoparticles; pharmaceutical preparations, such as, vaccines for human use; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics.

Class [42]
Computer & Software Services & Scientific Services


Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, such as, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, such as, conducting pharmacodynamic and pharmacokinetic studies, safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, and nucleic acid therapeutics; clinical research services, such as, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; research and development of new formulation products for others; research and development of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids,  messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology.

Class [45]
Personal & Legal & Social Services


Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid,messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology.

Mark Details


Serial Number

UK00003902781

Mark Type

Figurative

Kind of mark

Individual